Metastatic Colon Cancer Completed Phase 2 Trials for Imatinib (DB00619)

Also known as: Colon cancer metastatic / Stage IV Colon Cancer / Colon cancer stage IV / Malignant neoplasm of colon stage IV / Colon cancer Duke's D / Malignant neoplasm of colon stage IV, unspecified

IndicationStatusPhase
DBCOND0033231 (Metastatic Colon Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00041340Imatinib Mesylate in Treating Patients With Stage IV Colorectal CancerTreatment